← Product Code [DLJ](/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DLJ) · K983555 # ABUSCREEN ONLINE BENZ 200 CALIBRATORS (K983555) _Roche Diagnostic Systems, Inc. · DLJ · Dec 15, 1998 · Clinical Toxicology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DLJ/K983555 ## Device Facts - **Applicant:** Roche Diagnostic Systems, Inc. - **Product Code:** [DLJ](/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DLJ.md) - **Decision Date:** Dec 15, 1998 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 862.3200 - **Device Class:** Class 2 - **Review Panel:** Clinical Toxicology ## Indications for Use Abuscreen ONLINE BENZ 200 Calibrators are designed for the calibration of the Roche assays for Benzodiazepines. This clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. ## Device Story Abuscreen ONLINE BENZ 200 Calibrators serve as reference standards for calibrating Roche benzodiazepine assays. The device consists of a set of calibrators at specific concentrations (0, 100, 200, 400 ng/mL) in a urine matrix. Used in clinical laboratory settings by trained personnel, these calibrators allow the assay system to establish a calibration curve. This curve enables the quantitative or semi-quantitative determination of benzodiazepine levels in patient urine samples. By providing accurate reference points, the device ensures the reliability of the assay's output, which healthcare providers use to assess drug presence or concentration, aiding in clinical toxicology decision-making. ## Clinical Evidence No clinical or nonclinical tests were necessary to establish substantial equivalence. ## Technological Characteristics Clinical toxicology calibrator; matrix: urine; concentrations: 0, 100, 200, 400 ng/mL. Used for calibration of in vitro diagnostic assays. ## Regulatory Identification A clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. A clinical toxicology calibrator can be a mixture of drugs or a specific material for a particular drug (e.g., ethanol, lidocaine, etc.). (See also § 862.2 in this part.) ## Special Controls *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9. ## Predicate Devices - Abuscreen ONLINE Calibration Pack ([K951595](/device/K951595.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # DEC 1 4 1998 Image /page/0/Picture/1 description: The image shows the number K983555 at the top. Below the number is the Roche logo, which is a hexagon with the word Roche inside. The text and logo are in black and white. الموالي الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الموقع الم # 510(k) Summary # Abuscreen ONLINE® BENZ 200 Calibrators In accordance with the Safe Medical Devices Act of 1990, a 510(k) summary is provided as outlined in 21 CFR 807.92. The assigned 510(k) number is:_\983555 ## I. Identification of 510(k) Sponsor: Roche Diagnostic Systems, Inc. a subsidiary of Hoffmann-La Roche, Inc. Branchburg Township 1080 U.S. Highway 202 Somerville, New Jersey 08876-3771 510(k) Submission dated October 9, 1998 Contact: Maria Feijoo Manager, Regulatory Affairs Phone: (908) 253-7310 Fax: (908) 253-7547 ### II. Device Name: The device name, including both the trade/proprietary name and the classification name are provided in the table below. | Table 1 | | | | |------------------------------------------|----------------------------|-----------------|---------------------------------------| | Product Name | Classification
Name | Product
Code | CFR
Number and
Regulatory Class | | Abuscreen ONLINE BENZ 200
Calibrators | Calibrators, Drug Specific | DLJ | 862.3200
Class II | Tahlo 1 {1}------------------------------------------------ ## III. Identification of the legally marketed device to which the 510(k) sponsor claims equivalence: Table 2 The following table identifies the legally marketed devices to which Roche Diagnostic Systems, Inc. claims equivalence. | Product Name | Predicate Product
Name | 510(k) Number and Date
Predicate Cleared | |------------------------------------------|--------------------------------------|---------------------------------------------| | Abuscreen ONLINE BENZ 200
Calibrators | Abuscreen ONLINE Calibration
Pack | K951595 9/8/95 | ## IV. Description of the Device/Statement of Intended Use: Abuscreen ONLINE BENZ 200 Calibrators are designed for the calibration of the Roche assays for Benzodiazepines. This clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. ## V. Summary of the technological characteristics of the new device in comparison to those of the predicate. Tables 3 outlines the characteristics of the Abuscreen ONLINE BENZ 200 Calibrators in comparison to those of legally marketed predicate products. ## VI. Brief discussion of the clinical and nonclinical tests relied on for a determination of substantial equivalence: No clinical or nonclinical tests were necessary to establish substantial equivalence. {2}------------------------------------------------ # Comparison Summary | | Proposed:
Abuscreen ONLINE BENZ
200 Calibrators | Previously Cleared:
(K951595)
Abuscreen ONLINE Calibration
Pack | |-----------------------------------------|------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------| | Matrix | urine | urine | | Intended use | for the calibration of Roche
assays for benzodiazepines | for the calibration of Roche
assays for amphetamines,
barbiturates, benzodiazepines,
cocaine metabolite,
methadone, opiates and pcp | | Levels of
Benzodiazepines
(ng/mL) | 0 | 0 | | | 100 | 50 | | | 200 | 100 | | | 400 | 200 | {3}------------------------------------------------ Image /page/3/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other. DEC 15 1998 Food and Drug Administration 2098 Gaither Road Rockville MD 20850 Mr. Maria Feijoo Manager, Regulatory Affairs Roche Diagnostic Systems, Inc. Branchburg Township 1080 U.S. Highway 202 Somerville, New Jersey 08876-3771 K983555 Re: : : Abuscreen ONLINE® BENZ 200 Calibrators Trade Name: Requlatory Class: ı i Product Code: DLJ Dated: October 9, 1998 Received: October 13, 1998 Dear Ms. Feijoo: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {4}------------------------------------------------ Page 2 This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diaqnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Steven Sutman Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ Page 1 of 1 510(k) Number (if known) Device Name: Abuscreen ONLINE® BENZ 200 Calibrators Indications for Use: Abuscreen ONLINE BENZ 200 Calibrators are designed for the calibration of the Roche assays for Benzodiazepines. This clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. ## (PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) (Division Sign-Off) Divisio linical Laboratory Devices 510(k) Number. K983555 --- **Source:** [https://fda.innolitics.com/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DLJ/K983555](https://fda.innolitics.com/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DLJ/K983555) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com